Cargando…

Risk-benefit of AstraZeneca COVID-19 vaccination in Australia

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642228/ http://dx.doi.org/10.1007/s40278-021-06332-8

Ejemplares similares

AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)

AstraZeneca COVID-19 vaccine: no increased rate of VTE
Publicado: (2021)

AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis
Publicado: (2021)

Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Increased risk of immune thrombocytopenia following AstraZeneca Covid-19 vaccine
Publicado: (2021)

AstraZeneca COVID-19 vaccine recommended in ≥50s in Australia
Publicado: (2021)

Lipschütz ulcers after AstraZeneca COVID-19 vaccination()
por: Bracho-Borro, Maria, et al.
Publicado: (2023)

AstraZeneca and Pfizer-BioNTech COVID-19 vaccines: AEs in South Korea
Publicado: (2021)

Benefits of COVID-19 Vaccine AstraZeneca outweigh risks of blood clots
Publicado: (2021)

No increased risk of anaphylaxis with AstraZeneca COVID-19 vaccine
Publicado: (2021)

AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021)

Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021)

Bleeding and clotting with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Canadian findings on AstraZeneca COVID-19 Vaccine and COVISHIELD
Publicado: (2021)

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Ischemic stroke after AstraZeneca (Covid-19) vaccination
por: Alammar, Muath A.
Publicado: (2021)

Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine
por: Agharbi, F.-Z., et al.
Publicado: (2022)

Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework
por: Lau, Colleen L., et al.
Publicado: (2021)

AstraZeneca COVID-19 Vaccine-related risk of capillary leak syndrome
Publicado: (2021)

Vaccin Oxford/AstraZeneca, mode d’emploi
por: Dalmat, Yann-Mickael
Publicado: (2021)

Health Canada: blood clots with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Denmark ceases roll out of AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
por: Allen-Philbey, K., et al.
Publicado: (2021)

Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()
por: Crespo Burillo, J.A., et al.
Publicado: (2021)

Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine
por: Mayfield, Helen J., et al.
Publicado: (2022)

Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?
por: Østergaard, Søren Dinesen, et al.
Publicado: (2021)

AstraZeneca COVID-19 vaccine not recommended in adults under 55 in Canada
Publicado: (2021)

Ongoing evaluation of COVID-19 Vaccine AstraZeneca-related blood clots
Publicado: (2021)

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
por: Morlidge, Clare, et al.
Publicado: (2021)

An analysis of AstraZeneca COVID-19 vaccine misinformation and fear mongering on Twitter
por: Jemielniak, D., et al.
Publicado: (2021)

Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021)

Who funded the research behind the Oxford–AstraZeneca COVID-19 vaccine?
por: Cross, Samuel, et al.
Publicado: (2021)

[Translated article] Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine
por: González-Romero, N., et al.
Publicado: (2022)

Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID‐19 vaccination
por: Wang, Huei‐Jing, et al.
Publicado: (2022)

Erythema nodosum following the first dose of AstraZeneca COVID-19 vaccine
por: Berrim, K., et al.
Publicado: (2023)

AstraZeneca COVID-19 vaccine: EMA continues review of rare blood clots
Publicado: (2021)

EMA assessing cases of blood clots after AstraZeneca COVID-19 vaccine
Publicado: (2021)

Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia
por: Garnier, Matthieu, et al.
Publicado: (2021)

Updated advice on thrombosis with thrombocytopenia syndrome and use of COVID-19 Vaccine AstraZeneca
Publicado: (2021)

Immunogenicity of Oxford-AstraZeneca COVID-19 Vaccine in Vietnamese Health-Care Workers
por: Chau, Nguyen Van Vinh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gmh69el10ma09v4e83jbo14hqh